LRMR R&D Expense Growth
Larimar Therapeutics Inc · R&D Expense Growth
LRMR R&D Expense Growth
Latest reported110.46%period ending
LRMR FY R&D Growth (YoY) (0.00% → 110.46%)
Latest values, visible window
High-resolution chart · PNG
LRMR r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 110.4643% | |
| 164.8283% | |
| 14.1031% | |
| -36.8424% | |
| 22.8593% | |
| 50.3223% | |
| -58.0246% | |
| 18.6636% | |
| 4.9404% | |
| -27.1779% | |
| 99.4013% | |
| 186.4868% | |
| -17.1778% | |
| 1.2365% | |
| 0% |